Skip to main content

Table 1 Patients’ characteristics

From: Low Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms

Patients Number
MDS 10
 Gender
  Male/Female 5/5
 Age (years), median (range): 58 (28–78)
  WHO 2008  
  RA 2
  RARS 1
  RCMD 4
  RAEB-1 3
  IPSS-R  
  Low 5
  Intermediate 2
  High 1
  Not available 2
 Cytogenetics
  Normal karyotype 10
 BM blast (%)
  <5 % 7
  ≥5 and <10 % 3
AML 9
 Gender
  Male/Female 4/5
 Age (years), median (range) 66 (44–90)
 BM blasts (%), median (range) 92 (31–98.5)
 Cytogenetics
  Normal karyotype 2
  Deletion 5q 1
  Monosomy 7 1
  Complex karyotype 1
  No growth 4
  1. Abbreviations: MDS myelodysplastic syndromes, WHO World Health Organization, RA refractory anemia, RARS refractory anemia with ringed sideroblasts, del(5q) MDS with isolated del(5q), RCMD refractory cytopenia with multilineage dysplasia, RAEB-1 refractory anemia with excess blast-1, BM bone marrow, IPSS-R Revised International Prognostic Scoring System, AML acute myeloid leukemia